Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Cellular Dynamics to Host Annual iForum(TM) Meetings Focused on Differentiated Human iPS Cell Innovations and Applications | ||
| By: PR Newswire Association LLC. - 30 Jun 2016 | Back to overview list |
|
MADISON, Wis., June 30, 2016 /PRNewswire/ -- Cellular Dynamics International (CDI), a FUJIFILM company, today announced that the company will host the iForum™ 2016 Meeting: US in Philadelphia from Sept. 12-14 and the iForum 2016 Meeting: Europe in Paris on Oct. 11. Annual iForum events provide attendees with a unique opportunity to connect with thought leaders from academia, government, biotech and pharma to discover new applications and uses for differentiated induced pluripotent stem (iPS) cells. The iForum 2016 Meetings will focus on real-life implementation of human iPS cell technologies. The meetings will include scientific talks, poster sessions, small group roundtables and additional networking opportunities. Key Points
Quote Kaz Hirao, CDI Chairman and CEO, said, "We look forward to hosting this forward-thinking community of scientists to accelerate the use of iPS cells in basic and translational research activities. Our hope is that iForum 2016 Meeting sessions will lead to a multitude of dynamic collaborations aimed at advancing the development of novel, effective and safe therapies that improve the quality of human life." About Cellular Dynamics International (CDI), a FUJIFILM company Cellular Dynamics International (CDI), a FUJIFILM company, is a leading developer and manufacturer of human cells used in drug discovery, toxicity testing, stem cell banking and cell therapy development. The Company partners with innovators from around the world to combine biologically relevant human cells with the newest technologies to drive advancements in medicine and healthier living. CDI's technology offers the potential to create induced pluripotent stem cells (iPSCs) from anyone, starting with a standard blood draw, and followed by the powerful capability to develop into virtually any cell type in the human body. Our proprietary manufacturing system produces billions of cells daily, resulting in inventoried iCell® products and donor-specific MyCell® Products in the quantity, quality, purity, and reproducibility required for drug and cell therapy development. Founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research, CDI is based in Madison, Wisconsin, with a second facility in Novato, California. For more information please visit www.cellulardynamics.com and follow us on Twitter @CellDynamics. About FUJIFILM FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2015, the company had global revenues of $20.8 billion, at an exchange rate of 120 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com. All product and company names herein may be trademarks of their registered owners. MEDIA CONTACTS: Tony Russo, Ph.D., or Rich Allan Lisabeth Weiner SOURCE Cellular Dynamics International (CDI), a FUJIFILM company 
|
||
|
||
 | Back to overview list | |